Esophageal Squamour Cell Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Esophageal Squamour Cell Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

Not Yet RecruitingPhase 2

NCT07191977

Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinoma

The goal of this Phase 2 clinical trial is to learn if the combination of Camrelizumab and Palbociclib is a safe and effective treatment when given before surge…

Location not specified41 participantsStarted 2026-01

Treatment: Camrelizumab, Palbociclib

Not Yet RecruitingPhase 2

NCT06814158

Neoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer

Neoadjuvant ChemoRadioTherapy (NCRT) combined with surgical resection is the standard treatment for locally advanced esophageal squamous cell carcinoma (ESCC) b…

China57 participantsStarted 2025-03-01

Treatment: Ivonescimab Combined With Chemotherapy